Castanheira G, Amato V, Tuon F, Dantas L, de Carvalho S, Vieira T
Eur J Clin Microbiol Infect Dis. 2025; 44(3):717-728.
PMID: 39808375
DOI: 10.1007/s10096-025-05037-4.
Urdapilleta A, Santos Alfani A, Barroso D, Vinecky F, Amaral Vaz Bandeira S, Andrade A
Biomedicines. 2024; 12(10).
PMID: 39457540
PMC: 11504370.
DOI: 10.3390/biomedicines12102227.
Bueno Filho R, Feres J, Paula N, Barros Junior S, Roselino A
An Bras Dermatol. 2024; 99(3):472-475.
PMID: 38403555
PMC: 11074554.
DOI: 10.1016/j.abd.2023.06.008.
Leal J, Barroso D, Trindade N, de Miranda V, Gurgel-Goncalves R
Biomedicines. 2024; 12(1).
PMID: 38275373
PMC: 10813291.
DOI: 10.3390/biomedicines12010012.
Montoya A, Gil E, Vinales I, Estevao I, Taboada P, Torrico M
Carbohydr Res. 2024; 536:109015.
PMID: 38198982
PMC: 11366264.
DOI: 10.1016/j.carres.2023.109015.
Accuracy of serological tests in diagnosing mucosal leishmaniasis.
Oliveira D, Lopes K, Avelar D, Cota G, Oliveira E
Parasitol Res. 2023; 122(9):2001-2010.
PMID: 37391643
DOI: 10.1007/s00436-023-07900-9.
Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a -endemic area.
Barroso D, Goncalves R, Barbosa J, da Motta J, Freire G, Gomes C
Front Cell Infect Microbiol. 2022; 12:993338.
PMID: 36211958
PMC: 9538529.
DOI: 10.3389/fcimb.2022.993338.
Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins.
Viana S, Montoya A, Carvalho A, de Mendonca B, Portillo S, Olivas J
Emerg Microbes Infect. 2022; 11(1):2147-2159.
PMID: 36039908
PMC: 9518598.
DOI: 10.1080/22221751.2022.2114852.
The Presence of DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study.
Barroso D, Nobrega O, de Araujo C, Freire G, Martins S, Rodrigues B
Front Cell Infect Microbiol. 2021; 11:744163.
PMID: 34722337
PMC: 8551912.
DOI: 10.3389/fcimb.2021.744163.
Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis.
Garcia G, Carvalho A, Duarte M, Costa E Silva M, Medeiros F, Ferraz Coelho E
Appl Microbiol Biotechnol. 2021; 105(18):6805-6817.
PMID: 34432132
DOI: 10.1007/s00253-021-11518-1.
A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis.
Martins S, Barroso D, Rodrigues B, da Motta J, Freire G, Pereira L
Front Cell Infect Microbiol. 2021; 11:700323.
PMID: 34277476
PMC: 8281031.
DOI: 10.3389/fcimb.2021.700323.
Diagnostic performance of a Recombinant Polymerase Amplification Test-Lateral Flow (RPA-LF) for cutaneous leishmaniasis in an endemic setting of Colombia.
Cossio A, Jojoa J, Castro M, Castillo R, Osorio L, Shelite T
PLoS Negl Trop Dis. 2021; 15(4):e0009291.
PMID: 33909619
PMC: 8081229.
DOI: 10.1371/journal.pntd.0009291.
A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis.
Rodrigues B, Ferreira M, Barroso D, Motta J, Paula C, Porto C
Int J Parasitol Drugs Drug Resist. 2020; 14:257-263.
PMID: 33285343
PMC: 7723996.
DOI: 10.1016/j.ijpddr.2020.11.002.
Orofacial manifestations of mucocutaneous leishmaniasis: a case series from Brazil.
Falcao G, Lins-Kusterer L, Leite-Ribeiro P, Sarmento V
F1000Res. 2020; 8:756.
PMID: 33042516
PMC: 7527865.
DOI: 10.12688/f1000research.19056.3.
Identification of Leishmania species by high-resolution DNA dissociation in cases of American cutaneous leishmaniasis.
Veasey J, Andrade Zampieri R, Lellis R, Freitas T, Winter L
An Bras Dermatol. 2020; 95(4):459-468.
PMID: 32518010
PMC: 7335872.
DOI: 10.1016/j.abd.2020.02.003.
The accuracy of the Montenegro skin test for leishmaniasis in PCR-negative patients.
Pinheiro A, Kurizky P, Ferreira M, Mota M, Ribeiro J, Oliveira Filho E
Rev Soc Bras Med Trop. 2020; 53:e20190433.
PMID: 32348430
PMC: 7198066.
DOI: 10.1590/0037-8682-0433-2019.
Tegumentary leishmaniasis mimicking visceralization in a cirrhotic patient: atypical cutaneous lesions and local immunological features.
Vernal S, Casal Y, Vieira L, Amato V, Duarte M, Nastri A
Rev Soc Bras Med Trop. 2020; 53:e20190380.
PMID: 31994668
PMC: 7083368.
DOI: 10.1590/0037-8682-0380-2019.
Diagnosing Cutaneous leishmaniasis using Fluorescence Hybridization: the Sri Lankan Perspective.
Jayasena Kaluarachchi T, Weerasekera M, McBain A, Ranasinghe S, Wickremasinghe R, Yasawardene S
Pathog Glob Health. 2019; 113(4):180-190.
PMID: 31429388
PMC: 6758699.
DOI: 10.1080/20477724.2019.1650228.
Cutaneous leishmaniasis mimicking cutaneous lymphoma.
Pires C, Pereira N, Moreira A, Sena J, Costa C, Bastos T
IDCases. 2019; 17:e00580.
PMID: 31338298
PMC: 6627646.
DOI: 10.1016/j.idcr.2019.e00580.
Tegumentary leishmaniasis diagnosis: what happened with MST (Montenegro Skin Test) in Brazil?.
Braz L
Rev Inst Med Trop Sao Paulo. 2019; 61:e17.
PMID: 30864622
PMC: 6413772.
DOI: 10.1590/S1678-9946201961017.